Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China
The Journal of Clinical Endocrinology & Metabolism · 18.12.2024 · 110 (1) · e132-e139
DOI: 10.1210/clinem/dgae116 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.03.2024. Verfasst von Wenqing Ni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Elderly Health Management, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, 518020, China. Hauptthemen laut MEDLINE: Cholesterol, LDL, Cause of Death, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Medical Scientific Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Context
Limited information was available on detailed associations of low-density lipoprotein cholesterol (LDL-C) with all-cause and cause-specific mortality in older adults.
Methods
This prospective cohort study included a representative sample of 211 290 adults aged 65 or older who participated in Shenzhen Healthy Aging Research 2018-2019. The vital status of the participants by December 31, 2021, was determined. We estimated the hazard ratios (HR) with 95% confidence intervals for all-cause or cause-specific mortality using multivariable Cox proportional hazards models and Cox models with restricted cubic spline (RCS).
Results
The median follow-up time was 3.08 years. A total of 5333 participants were confirmed to have died. Among them, 2037 cardiovascular disease (CVD) deaths and 1881 cancer deaths occurred. Compared to those with LDL-C of 100 to 129 mg/dL, the all-cause mortality risk was significantly higher for individuals with LDL-C levels that were very low (<70 mg/dL) or low (70-99 mg/dL). Compared with individuals with the reference LDL-C level, the multivariable-adjusted HR for CVD-specific mortality was 1.338 for those with very low LDL-C levels (< 70 mg/dL), 1.437 for those with high LDL-C levels (160 mg/dL ≤ LDL-C < 190 mg/dL), and 1.489 for those with very high LDL-C levels (≥190 mg/dL). Low LDL-C levels (70-99 mg/dL) and very low LDL-C levels (<70 mg/dL) were also associated with increased cancer mortality and other-cause mortality, respectively. The results from an RCS curve showed similar results.
Conclusion
Considering the risk of all-cause mortality and cause-specific mortality, we recommended 100 to 159 mg/dL as the optimal range of LDL-C among older adults in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Elderly Health Management, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, 518020, China.
- National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Bejing, 100021, China.
ORCID-Profile: Xiaoming Shi, Jian Xu
Förderung
- Medical Scientific Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Ni, W., Lv, Y., Yuan, X., Zhang, Y., Zhang, H., Zheng, Y., Shi, X., & Xu, J. (2024). Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China. The Journal of Clinical Endocrinology & Metabolism, 110(1), e132-e139. https://doi.org/10.1210/clinem/dgae116
Vancouver
Ni W, Lv Y, Yuan X, Zhang Y, Zhang H, Zheng Y, et al. Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China. The Journal of Clinical Endocrinology & Metabolism. 2024;110(1):e132-e139. doi:10.1210/clinem/dgae116
BibTeX
@article{Ni2024,
author = {Ni, Wenqing and Lv, Yuebin and Yuan, Xueli and Zhang, Yan and Zhang, Hongmin and Zheng, Yijing and Shi, Xiaoming and Xu, Jian},
title = {Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {110},
number = {1},
pages = {e132--e139},
doi = {10.1210/clinem/dgae116}
}
EUVIMED